HSA releases New Initiatives for Registration of Therapeutic Products- Aug 2021

As part of HSA’s ongoing efforts to enhance clarity in  regulatory requirements and processes, and make regulatory information easily accessible to encourage good submission practices by the industry, the HSA has introduced an online self-guided tool for post-approval minor variations application and a DMF acknowledgment email and guidance on deficiency matters.